Skip to Main Content

1,477

Views

0

CrossRef citations to date

0

Altmetric

Novel Vaccines

Formulation development of a stable influenza recombinant neuraminidase vaccine candidate

Bing Lia Sanofi Global Vaccine Drug Product Development, Toronto, ON, CanadaView further author information

,

Irina V. Ustyugovab Sanofi Global Immunology, Waltham, MA, USAView further author information

,

Lisa Szymkowiczc Sanofi Analytical Sciences, Toronto, ON, CanadaView further author information

,

Shaolong Zhuc Sanofi Analytical Sciences, Toronto, ON, CanadaView further author information

,

Marin Mingc Sanofi Analytical Sciences, Toronto, ON, CanadaView further author information

,

Karen Y. Y. Funga Sanofi Global Vaccine Drug Product Development, Toronto, ON, CanadaView further author information

,

Guadalupe Cortésd Sanofi mRNA & Translational Medicine COVID Franchise, Global Clinical Development, Waltham, MA, USAView further author information

,

D. Andrew Jamese Sanofi External Research and Development, Toronto, ON, CanadaView further author information

,

Michael Hrynykf Sanofi Digital Program & Services, Toronto, ON, CanadaView further author information

,

Nausheen Rahmana Sanofi Global Vaccine Drug Product Development, Toronto, ON, CanadaView further author information

,

Roger H. Brookesa Sanofi Global Vaccine Drug Product Development, Toronto, ON, CanadaCorrespondence[email protected]

https://orcid.org/0000-0002-5361-0617 View further author information

&

Salvador F. Ausara Sanofi Global Vaccine Drug Product Development, Toronto, ON, CanadaView further author information